Growth Metrics

Aytu Biopharma (AYTU) Depreciation and Depletion (2016 - 2026)

Aytu Biopharma has reported Depreciation and Depletion over the past 13 years, most recently at $100000.0 for Q4 2025.

  • Quarterly Depreciation and Depletion changed 0.0% to $100000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $300000.0 through Dec 2025, down 40.0% year-over-year, with the annual reading at $200000.0 for FY2025, 77.78% down from the prior year.
  • Depreciation and Depletion was $100000.0 for Q4 2025 at Aytu Biopharma, roughly flat from $100000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $500000.0 in Q2 2021 and troughed at $100000.0 in Q2 2024.
  • The 5-year median for Depreciation and Depletion is $300000.0 (2022), against an average of $266666.7.
  • Year-over-year, Depreciation and Depletion surged 2122.22% in 2021 and then crashed 66.67% in 2024.
  • A 5-year view of Depreciation and Depletion shows it stood at $400000.0 in 2021, then changed by 0.0% to $400000.0 in 2022, then fell by 25.0% to $300000.0 in 2023, then crashed by 66.67% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Depreciation and Depletion are $100000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q1 2025).